EVERSOURCE ENERGY (ES) Stock News

Rosen Law Firm is urging investors who purchased Futu Holdings Limited securities between May 24, 2023 and May 27, 2026 to join a class action lawsuit. The lawsuit alleges that Futu made false statements and failed to disclose non-compliance with China Securities Regulatory Commission requirements, including conducting securities and futures business without proper licenses, which led to overstated financial results.

Rosen Law Firm is notifying investors who purchased Erasca, Inc. (ERAS) stock between January 14, 2025 and April 26, 2026 about a securities class action lawsuit. The lawsuit alleges that Erasca and its executives made false and misleading statements about its lead oncology drug candidate ERAS-0015, including improper comparisons to a competing drug and undisclosed patent disputes. The deadline to serve as lead plaintiff is August 10, 2026.

Rosen Law Firm is soliciting investors who purchased securities in Verra Mobility Corporation, Hub Group, Inc., and Via Transportation, Inc. during specified periods to join class action lawsuits. The firm alleges that Verra made materially false statements regarding its relationship with Avis Budget Group and concealed adverse facts about potential competition from in-house solutions.

Nvidia CEO Jensen Huang highlighted at CES 2026 that memory is becoming the critical bottleneck in AI development as large language models require increasing storage capacity. Memory and storage chip manufacturers Micron Technology and Sandisk have significantly outperformed Nvidia's stock since then, with both companies reporting surging revenues driven by AI infrastructure demand. Both companies are securing long-term customer contracts worth billions to stabilize their typically cyclical business.

Rosen Law Firm is urging investors who purchased Via Transportation, Inc. (NYSE: VIA) stock during its IPO to join a securities class action lawsuit before the August 10, 2026 deadline. The lawsuit alleges that Via's IPO offering documents were false and misleading, omitting information about declining Platform Annual Run-Rate Revenue and growth obstacles in Germany. Via's stock has declined approximately 70% from its IPO price to $14.52.

A securities class action lawsuit has been filed against AeroVironment, Inc. (AVAV) alleging the company made false and misleading statements regarding competition for U.S. Space Force contracts (SCAR and SCN programs). Investors who purchased securities between June 25, 2025 and March 10, 2026 may be eligible for compensation. The lead plaintiff deadline is July 27, 2026.

Rosen Law Firm has filed securities class action lawsuits against First Solar, Inc., Photronics, Inc., and Intuit Inc. The First Solar lawsuit alleges the company made materially false statements regarding its capacity to manage U.S. tariff policy impacts and overstated projected performance for fiscal year 2026. Investors who purchased securities during specified class periods are encouraged to join the litigation before the August 24, 2026 lead plaintiff deadline.

Rosen Law Firm has filed class action lawsuits against Intuit Inc., GRAIL Inc., and Genius Group Limited on behalf of investors who purchased securities during specified periods. The lawsuit against Intuit alleges the company made materially false statements about its competitive advantages and overstated TurboTax revenue growth guidance, while the company faced significant business losses due to competitive pressures. Investors are encouraged to join the class action or serve as lead plaintiff before the September 8, 2026 deadline.

A securities class action lawsuit has been filed against GRAIL, Inc. for allegedly providing misleading statements about its NHS-Galleri trial results. The company allegedly concealed material adverse facts about the trial's ability to demonstrate a reduction in Stage III-IV cancers. Investors who purchased GRAIL common stock between May 13, 2025 and February 19, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is August 4, 2026.

A securities class action lawsuit has been filed against Veritone, Inc. (NASDAQ: VERI) for allegedly making false and misleading statements regarding its financial reporting. The lawsuit claims the company inaccurately recorded revenue and costs, overstated financial metrics, and maintained deficient internal controls, leading to required financial statement restatements. Investors who purchased securities between October 14, 2025 and April 14, 2026 may be eligible for compensation. The lead plaintiff deadline is July 20, 2026.

Rosen Law Firm is encouraging investors who purchased securities of Insulet Corporation (PODD) between February 21, 2025 and May 26, 2026 to join a class action lawsuit. The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures that created a foreseeable risk of product safety violations. The lead plaintiff deadline is August 31, 2026.

Rosen Law Firm has filed securities class action lawsuits against BitGo Holdings, Intuit Inc., and GRAIL, Inc., alleging that offering documents contained materially false and misleading statements. BitGo is accused of understating risks related to declining digital asset prices. Investors who purchased securities during specified class periods are encouraged to join the litigation before the August 7, 2026 lead plaintiff deadline.

A securities class action lawsuit has been filed against Badger Meter, Inc. (NYSE: BMI) alleging that the company made materially false and misleading statements about its financial results and growth prospects during the Class Period (April 18, 2024 - April 16, 2026). The lawsuit claims Badger Meter artificially inflated results by pulling forward customer orders to recognize revenue early, concealing weakening demand and deteriorating order trends. The lead plaintiff deadline is August 3, 2026.

Law firm Kirby McInerney LLP is investigating potential securities fraud claims against Pentair plc following the company's July 14, 2026 announcement of significantly reduced financial guidance and immediate CFO departure. Pentair reported Q2 sales of ~$930M (17% decline vs. expected 1% growth) and adjusted EPS of ~$1.12 (vs. prior guidance of $1.47-$1.50), citing inventory realignment issues and worsening business conditions. The stock fell 15% to $64.33 on the news.

A securities class action lawsuit has been filed against Sportradar Group AG, alleging the company made false statements about compliance with regulations and worked with black-market gambling operators while claiming strict legal adherence. Investors who purchased shares between November 7, 2024 and April 21, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is July 17, 2026.

Law firm Bragar Eagel & Squire is investigating Pentair plc for potential securities law violations following the company's July 15, 2026 announcement of significantly lowered 2026 outlook, $170 million inventory destocking impact on Pool segment sales, and immediate CFO departure. Pentair's stock fell 15% ($11.35) to $64.33 per share on the news.

Compass Therapeutics announced that its abstract for tovecimig, a DLL4 x VEGF-A bispecific antibody, has been accepted for an oral presentation at the ESMO Congress 2026 in Madrid. The presentation will showcase Phase 2/3 COMPANION-002 trial results evaluating tovecimig combined with paclitaxel in patients with advanced biliary tract cancer, to be presented by Dr. Nilofer Azad from Johns Hopkins University on October 24, 2026.

Click Holdings Limited announced it has delivered over 6 million cumulative senior care service hours and unveiled a global ESG framework to support expansion into Mainland China and international markets. The company reported 73% year-over-year Q3 revenue growth with 110% growth in its senior nursing division, and targets HK$500 million in annual revenue within three years by leveraging its AI-powered HR and senior care solutions.

Rosen Law Firm has filed class action lawsuits against GPGI, Inc. (formerly CompoSecure), Lucid Group, Inc., and Nano-X Imaging Ltd. on behalf of investors who suffered losses. The GPGI lawsuit alleges defendants made materially false statements regarding the Husky acquisition valuation and financial targets. Investors are encouraged to secure counsel before important deadlines.

Rosen Law Firm is reminding investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 of an important August 11, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that necessitated restructuring.

Rosen Law Firm is encouraging investors who suffered losses in Calix, Inc., Microsoft Corporation, and Alarum Technologies Ltd. to join securities class action lawsuits. The Calix lawsuit alleges the company made false statements about margins by failing to disclose that advanced memory component purchases were dwindling and that the company faced negative margin pressure. A July 27, 2026 deadline applies for lead plaintiff claims in the Calix case.

A securities class action lawsuit has been filed against Zoetis Inc. for allegedly making false and misleading statements about its Companion Animal products during the period of January 14, 2025 to May 6, 2026. The lawsuit claims the company failed to disclose weakening veterinarian adoption of its flagship products Librela, Simparica Trio, and dermatology treatments Apoquel and Cytopoint due to safety concerns, competition, and market share losses. Investors with losses exceeding $100,000 are encouraged to join the class action before the July 27, 2026 lead plaintiff deadline.

A securities class action lawsuit has been filed against PicS N.V. following its January 2026 IPO. The lawsuit alleges that defendants made false and misleading statements regarding credit evaluation procedures, loan quality, and financial risks. Investors who purchased Class A common stock have until August 4, 2026 to serve as lead plaintiff.

Rosen Law Firm is urging investors who purchased Verra Mobility Corporation (VRRM) stock between February 24, 2026 and May 26, 2026 to join a securities class action lawsuit. The lawsuit alleges that Verra made materially false and misleading statements regarding its relationship with Avis Budget Group and contract extension prospects, while downplaying risks of major rental car companies developing in-house alternatives. The lead plaintiff deadline is August 4, 2026.

ARCpoint Inc. (TSXV: ARC), a healthcare technology company, announced it will miss its July 29, 2026 filing deadline for annual financial statements due to lack of available funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and expects to file by September 29, 2026. During the MCTO period, insiders will be restricted from trading shares, though public trading will continue.

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to inflate EBITDA and financial results for 2024-2025. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

A securities class action lawsuit has been filed against GPGI, Inc. on behalf of investors who purchased Class A common stock between November 3, 2025 and May 6, 2026. The lawsuit alleges the company made materially false and misleading statements regarding business operations, growth prospects, and financial stability, causing the stock to trade at artificially inflated prices. Investors suffered significant losses when the truth was disclosed.

Law firm Robbins Geller Rudman & Dowd LLP announced class action lawsuits against GRAIL, Inc. (NASDAQ: GRAL) for allegedly making false statements about its NHS-Galleri cancer screening trial. GRAIL failed to achieve the primary endpoint of reducing Stage III-IV cancers, causing the stock to fall over 50% on February 19, 2026. The firm is seeking lead plaintiffs from investors who purchased GRAL stock between May 13, 2025 and February 19, 2026. Similar lawsuits were also filed against Commvault Systems, Inc. and PicS N.V.

A securities class action lawsuit has been filed against AeroVironment, Inc. for allegedly making false and misleading statements about competition risks related to U.S. Space Force contracts (SCAR and SCN programs). Investors who purchased securities between June 25, 2025 and March 10, 2026 may be eligible for compensation. The lead plaintiff deadline is July 27, 2026.

Robbins Geller announces that PicS N.V. investors have until August 4, 2026 to seek lead plaintiff status in a class action lawsuit alleging the company made false statements in its January 2026 IPO regarding credit evaluation procedures, loan quality, and financial risks. The stock has declined over 50% from its $19 IPO price to below $9 per share by June 2026.